Generic Name: Saxagliptin + metformin
Brand Name: Komboglyze
Manufacturer: AstraZeneca Canada Inc.
Therapeutic Area: Diabetes Mellitus, type 2
Indications: Diabetes Mellitus, Type 2
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: June 20, 2014
Recommendation Type: List with criteria/condition